These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 761943)

  • 1. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo.
    Schirrmacher V; Shantz G; Clauer K; Komitowski D; Zimmermann HP; Lohmann-Matthes ML
    Int J Cancer; 1979 Feb; 23(2):233-44. PubMed ID: 761943
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro.
    Bosslet K; Schirrmacher V; Shantz G
    Int J Cancer; 1979 Sep; 24(3):303-13. PubMed ID: 314938
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice.
    Schirrmacher V
    Int J Cancer; 1979 Jul; 24(1):80-6. PubMed ID: 314423
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. 2. Characteristics of a metastasizing variant of a chemically induced lymphoma.
    Schirrmacher V; Shantz G
    Adv Exp Med Biol; 1979; 114():769-75. PubMed ID: 463668
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes.
    Schirrmacher V; Bosslet K; Shantz G; Clauer K; Hübsch D
    Int J Cancer; 1979 Feb; 23(2):245-52. PubMed ID: 83969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F1 resistance to AKR lymphoma cells in vivo and in vitro.
    Schmitt-Verhulst A-M ; Zatz MM
    J Immunol; 1977 Jan; 118(1):330-3. PubMed ID: 830755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of host immunological resistance to syngeneic lymphoma using whole body irradiation.
    Maruyama Y
    Int J Radiat Oncol Biol Phys; 1976; 1(11-12):1159-69. PubMed ID: 993092
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of tumor growth by dinitrochlorobenzene (DNCB).
    Jessup JM; Riggs C; Cohen MH
    Surg Forum; 1976; 27(62):136-7. PubMed ID: 1019830
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphoma cell interaction with cultured vascular endothelial cells and with the subendothelial basal lamina: attachment, invasion and morphological appearance.
    Vlodavsky I; Schirrmacher V; Ariav Y; Fuks Z
    Invasion Metastasis; 1983; 3(2):81-97. PubMed ID: 6677623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discussion paper: the immune status of the murine host bearing transplantable syngeneic growing tumors.
    Manson LA
    Ann N Y Acad Sci; 1976; 276():272-5. PubMed ID: 829206
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of tumor size and surgical resection on cell-mediated immunity in mice.
    Whitney RB; Levy JG; Smith AG
    J Natl Cancer Inst; 1974 Jul; 53(1):111-6. PubMed ID: 4835101
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor.
    Wiltrout RH; Frost P
    J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
    Rao VS; Bonavida B
    Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and experimental morphologic parameters predictive of tumor metastasis.
    Crissman JD; Hatfield JS; Honn KV
    Prog Clin Biol Res; 1986; 212():251-67. PubMed ID: 3714731
    [No Abstract]   [Full Text] [Related]  

  • 16. Invasion of lymphosarcoma cells into the perfused mouse liver.
    Roos E; Dingemans KP; van de Pavert IV; van den Bergh-Weerman M
    J Natl Cancer Inst; 1977 Feb; 58(2):399-407. PubMed ID: 576239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VII. Interaction of metastasizing and nonmetastasizing tumors with normal tissue in vitro.
    Lohmann-Matthes ML; Schleich A; Shantz G; Schirrmacher V
    J Natl Cancer Inst; 1980 Jun; 64(6):1413-25. PubMed ID: 6929378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor progression and homeostasis.
    Prehn RT
    Adv Cancer Res; 1976; 23():203-36. PubMed ID: 775933
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-mediated changes of tumour cell immunogenicity and antigenicity.
    Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC
    Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-specific cytotoxicity of spleen cells in mice bearing transplanted chemically induced fibrosarcomas.
    Mantovani A; Evans R; Alexander P
    Br J Cancer; 1977 Jul; 36(1):35-40. PubMed ID: 889683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.